8 completed, 2 unknown, 1 withdrawn. 11 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 8, Unknown 2, Withdrawn 1 |
Follow ganirelix: new trials by email Literature Review of ganirelix trials Research Report on ganirelix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference GenSci094, Placebo RecFSH / follitropin alfa, Biological: RecFSH / Follitropin alfa (Days 1 to 7) - Infertility | Phase 3 | Completed | Changchun GeneScience Pharmaceutical Co., Ltd. | 176 | 2023-03-24 | 2024-12-03 |
| Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Progesterone, GnRH Antagonist - IVF, GnRH Antagonist | Phase 3 | Completed | ShangHai Ji Ai Genetics & IVF Institute | 784 | 2020-06-04 | 2023-08-30 |
| Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation Provera 10 mg., Ganirelix (GnRH antagonist) - Infertility | Phase 3 | Completed | Instituto Valenciano de Infertilidad, IVI VALENCIA | 318 | 2017-10-20 | 2021-08-25 |
| An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029) MK-8962, recFSH, Ganirelix - Infertility | Phase 3 | Withdrawn | Organon and Co | 2014-03-01 | 2022-02-03 | |
| Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response. Ganirelix 0.25 mg., Recombinant choriogonadotropin alfa, Micronized natural progesterone. - Infertility | Phase 3 | Completed | Instituto de Investigacion Sanitaria La Fe | 234 | 2013-09-01 | 2017-06-12 |
| Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial Corifollitropin alfa, recombinant FSH, Ganirelix - Infertility, Poor Ovarian Response | Phase 3 | Completed | Universitair Ziekenhuis Brussel | 150 | 2013-03-01 | 2016-06-23 |
| The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol ghrh antagonist (cetrotide/orgalutran), gnrh agonist (suprefact) - Embryo's Genetic and Chromosomal Quality | Phase 3 | Unknown | European Hospital | 200 | 2012-09-01 | 2012-07-10 |
| Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH ganirelix, suprefact - Infertility | Phase 3 | Unknown | Yazd Research & Clinical Center for Infertility | 2 | 2008-03-01 | 2009-01-15 |
| A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703) ganirelix, triptorelin - Controlled Ovarian Stimulation | Phase 3 | Completed | Organon and Co | 259 | 2007-05-01 | 2022-02-03 |
| To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) corifollitropin alfa (Org 36286), recFSH (follitropin beta), gonadatropin releasing hormone (GnRH) antagonist (ganirelix) - Infertility | Phase 3 | Completed | Organon and Co | 397 | 2006-12-28 | 2024-06-18 |
| A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787) Corifollitropin alfa, RecFSH / Follitropin beta (Days 1 to 7), Placebo Corifollitropin alfa - In Vitro Fertilization | Phase 3 | Completed | Organon and Co | 1509 | 2006-06-27 | 2024-06-20 |
Infertility (8) · Helping Behavior (1)
Organon and Co (4) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · European Hospital (1) · Instituto Valenciano de Infertilidad, IVI VALENCIA (1) · Instituto de Investigacion Sanitaria La Fe (1) · ShangHai Ji Ai Genetics & IVF Institute (1) · Universitair Ziekenhuis Brussel (1) · Yazd Research & Clinical Center for Infertility (1)
China (2) · Spain (2) · Belgium (1) · Iran (1) · Italy (1) · Vietnam (1)
Juan Giles, MD PhD (1) · Nikolaos P Polyzos, MD PhD (1) · Roser Taroncher (1)
PMID 26950065, PMID 26991902, PMID 19684043, PMID 20483664, PMID 20843746, PMID 22429192, PMID 23758821, PMID 24903202, PMID 27619773, PMID 29040589, PMID 33814126, PMID 38272383
2004 (1)